Macular Degeneration Clinical Trials

• A Study to Evaluate Retisert in the Treatment of Patients with the "wet" form of Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00032396 - Active, not recruiting
  Macular Degeneration
  
• Extension Study of rhuFab V2 in Subjects with Neovascular Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00095433 - Active, not recruiting
  Macular Degeneration
  
• Age-Related Macular Degeneration and Cataract
  ClinicalTrials.gov Identifier: NCT00001312 - Active, not recruiting
  Cataract; Macular Degeneration
  
• Preventing Depression in Patients with Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00042211 - Active, not recruiting
  Depression; Macular Degeneration
  
• Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00078221 - Active, not recruiting
  Macular Degeneration
  
• Randomized Trial of Beta-Carotene and Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00000152 - Active, not recruiting
  Macular Degeneration
  
• Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00157976 - Recruiting
  Macular Degeneration
  
• Genetic Factors in Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00058695 - Recruiting
  Macular Degeneration
  
• A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00447954 - Active, not recruiting
  Macular Degeneration
  
• Study of Sirna-027 in Patients With Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00495742 - Active, not recruiting
  Macular Degeneration; Choroidal Neovascularization
  
• Anecortave Acetate in Patients With Exudative Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00299507 - Active, not recruiting
  Macular Degeneration
  
• Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00259753 - Active, not recruiting
  Macular Degeneration
  
• Safety and Tolerability of Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Neovascular Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00320775 - Active, not recruiting
  Macular Degeneration
  
• Treatment of Age-Related Macular Degeneration With Anecortave Acetate
  ClinicalTrials.gov Identifier: NCT00211458 - Active, not recruiting
  Macular Degeneration
  
• Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00320788 - Active, not recruiting
  Macular Degeneration
  
• Submacular Surgery Trials (SST)
  ClinicalTrials.gov Identifier: NCT00000150 - Active, not recruiting
  Macular Degeneration; Histoplasmosis
  
• Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00414206 - Recruiting
  Macular Degeneration
  
• A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00454389 - Recruiting
  Macular Degeneration
  
• Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions
  ClinicalTrials.gov Identifier: NCT00324116 - Recruiting
  Macular Degeneration
  
• Clinical Study Of EYE001 For Wet-Type Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00239928 - Recruiting
  Macular Degeneration
  
• Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00304954 - Recruiting
  Macular Degeneration; Neovascularization
  
• Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00460408 - Recruiting
  Macular Degeneration
  
• Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00395707 - Recruiting
  Macular Degeneration
  
• Macular Photocoagulation Study (MPS)
  ClinicalTrials.gov Identifier: NCT00000158 - Active, not recruiting
  Choroidal Neovascularization; Macular Degeneration; Histoplasmosis
  
• Complications of Age-Related Macular Degeneration Prevention Trial (CAPT)
  ClinicalTrials.gov Identifier: NCT00000167 - Completed
  Macular Degeneration
  
• Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)
  ClinicalTrials.gov Identifier: NCT00150202 - Completed
  Macular Degeneration
  
• Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00100009 - Completed
  Macular Degeneration
  
• Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
  ClinicalTrials.gov Identifier: NCT00100087 - Recruiting
  Macular Degeneration; Choroidal Neovascularization
  
• Combination Therapy for Neovascular Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00447031 - Recruiting
  Macular Degeneration
  
• Oxidative Stress in Patients With Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00465400 - Recruiting
  Macular Degeneration
  
• Systemic Avastin Therapy in Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00531024 - Recruiting
  Macular Degeneration
  
• EXCITE - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (ARMD)
  ClinicalTrials.gov Identifier: NCT00275821 - Active, not recruiting
  Age-Related Macular Degeneration
  
• Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00470678 - Active, not recruiting
  Choroidal Neovascularization; Macular Degeneration
  
• Effects of Sun Filters on Age-Related Macular Degeneration in People With Lens Implants
  ClinicalTrials.gov Identifier: NCT00487838 - Recruiting
  Age-Related Macular Changes; Age-Related Macular Degeneration; Cataract and IOL Surgery; Retinal Photochemistry
  
• Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population
  ClinicalTrials.gov Identifier: NCT00533754 - Active, not recruiting
  Age-Related Macular Degeneration
  
• Randomized Trials of Vitamin Supplements and Eye Disease
  ClinicalTrials.gov Identifier: NCT00000161 - Active, not recruiting
  Macular Degeneration; Cataract
  
• A Trial to Assess the Safety and Tolerability of Repeated Doses of Intravitreal Administration of Two VEGF Trap Formulations in Subjects With Neovascular Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00383370 - Active, not recruiting
  Neovascular Age Related Macular Degeneration
  
• Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00429936 - Recruiting
  Macular Degeneration; Atrophy
  
• Age-Related Eye Disease Study (AREDS)
  ClinicalTrials.gov Identifier: NCT00000145 - Active, not recruiting
  Macular Degeneration; Cataract; Lens Opacities
  
• Safety Study of 16.5mg (3.3%) CGC-11047 Injected Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00446654 - Active, not recruiting
  Age Related Macular Degeneration
  
• Copaxone in Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00466076 - Recruiting
  Macular Degeneration
  
• Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD.
  ClinicalTrials.gov Identifier: NCT00041483 - Active, not recruiting
  Macular Degeneration
  
• Open-Label, Long-Term, Safety and Tolerability Study of Intravitreal VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00527423 - Not yet recruiting
  Macular Degeneration
  
• A Phase II Study of Implants of Encapsulated Human NTC-201 Cells Releasing Ciliary Neurotrophic Factor (CNTF) in Participants With Visual Acuity Impairment Associated With Atrophic Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00277134 - Active, not recruiting
  Visual Acuity Impairment; Atrophic Macular Degeneration
  
• Open-Label Posterior Juxtacleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients with AMD
  ClinicalTrials.gov Identifier: NCT00065728 - Recruiting
  Macular Degeneration
  
• The Effect of Eggs and Egg Products on the Macular Pigment
  ClinicalTrials.gov Identifier: NCT00527553 - Enrolling by invitation
  Age-Related Macular Degeneration
  
• A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00569140 - Recruiting
  Age-Related Macular Degeneration
  
• A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00395057 - Recruiting
  Choroid Neovascularization; Age-Related Macular Degeneration
  
• The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)
  ClinicalTrials.gov Identifier: NCT00485394 - Recruiting
  Age-Related Macular Degeneration
  
• Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00517010 - Recruiting
  Age-Related Macular Degeneration
  
• An evaluation of safety and efficacy of Anecortave Acetate vs. placebo in patients with subfoveal choroidal neovascularization(CNV) due to wet age-related macular degeneration(AMD)
  ClinicalTrials.gov Identifier: NCT00051129 - Active, not recruiting
  Macular Degeneration; Maculopathy, Age-Related; Age-Related Maculopathies; Age-Related Maculopathy; Maculopathies, Age-Related
  
• Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00423189 - Recruiting
  Age-Related Macular Degeneration
  
• Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy
  ClinicalTrials.gov Identifier: NCT00043680 - Completed
  Macular Degeneration
  
• Fundus Autofluorescence Imaging in Age-Related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy
  ClinicalTrials.gov Identifier: NCT00393692 - Recruiting
  Age-Related Macular Degeneration
  
• Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00473928 - Recruiting
  Age-Related Macular Degeneration
  
• Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Monotherapy - Intravitreal Ranibizumab Alone to Treat Age-Related Macular Degeneration.
  ClinicalTrials.gov Identifier: NCT00390208 - Active, not recruiting
  Age Related Macular Degeneration
  
• A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00251459 - Active, not recruiting
  Choroidal Neovascularization; Age-Related Macular Degeneration
  
• Pegaptanib Sodium on Foveal Thickening in Patients with Exudative Subfoveal Age-related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00087763 - Completed
  Macular Degeneration
  
• Laser and Medical Treatment of Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00050479 - Completed
  Macular Degeneration
  
• A Study to Evaluate rhuFab V2 in Subjects with Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00056836 - Completed
  Macular Degeneration
  
• An evaluation of safety and efficacy of Anecortave Acetate versus placebo in patients with subfoveal CNV due to exudative AMD.
  ClinicalTrials.gov Identifier: NCT00058994 - Active, not recruiting
  Macular Degeneration; Maculopathy, Age-Related
  
• SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00331864 - Active, not recruiting
  Age-Related Macular Degeneration; Choroidal Neovascularization
  
• Identification and Treatment of Feeder Vessels in Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00018070 - Completed
  Macular Degeneration
  
• A Study to Compare rhuFab V2 with Verteporfin Photodynamic in treating Subfoveal Neovascular Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00061594 - Completed
  Macular Degeneration
  
• Detection of Topographic Residual Acuity in Patients With Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00329277 - Recruiting
  Age-Related Macular Degeneration
  
• Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00443911 - Recruiting
  Age-Related Macular Degeneration
  
• Improving Function in Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00572039 - Enrolling by invitation
  Age-Related Macular Degeneration
  
• Effect of DHA Supplements on Macular Function in Patients with Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy
  ClinicalTrials.gov Identifier: NCT00060749 - Completed
  Macular Degeneration
  
• Intravitreous Pegaptanib Sodium Injection in patients with Exudative Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00088192 - Completed
  Macular Degeneration
  
• Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00347399 - Recruiting
  Age Related Macular Degeneration
  
• Changes in Retinal Function After Intravitreal Ranibizumab for Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00539734 - Recruiting
  Age-Related Macular Degeneration
  
• A Study of rhuFab V2 (ranibizumab) in Subjects with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00090623 - Completed
  Macular Degeneration
  
• Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.
  ClinicalTrials.gov Identifier: NCT00148551 - Active, not recruiting
  Age-Related Macular Degeneration
  
• Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00109499 - Completed
  Macular Degeneration
  
• Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00504959 - Active, not recruiting
  Subfoveal Choroidal Neovascularization (CNV); Secondary to Age-Related Macular Degeneration (AMD)
  
• OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00306488 - Recruiting
  Bilateral Geographic Atrophy; Age-Related Macular Degeneration; AMD
  
• Lutein for Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00006202 - Completed
  Macular Degeneration
  
• Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.
  ClinicalTrials.gov Identifier: NCT00346060 - Recruiting
  Dry Age Related Macular Degeneration.
  
• Selective RPE Laser Treatment (SRT) for Various Macular Diseases
  ClinicalTrials.gov Identifier: NCT00403884 - Recruiting
  Age-Related Macular Degeneration; Diabetic Maculopathy; Central Serous Chorioretinopathy
  
• Intravitreal Bevacizumab for Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00347165 - Recruiting
  Age Related Macular Degeneration
  
• Combination Therapy for Age-Related Macular Degeneration.
  ClinicalTrials.gov Identifier: NCT00376701 - Recruiting
  Age Related Macular Degeneration
  
• Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00220805 - Completed
  Macular Degeneration
  
• Pegaptanib Sodium Compared to Sham Injection in Patients with Recent Vision Loss due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
  ClinicalTrials.gov Identifier: NCT00088283 - Completed
  Macular Degeneration
  
• A Study on the Efficacy of Macugen Injections in Patients With Neovascular Age-Related Macular Degeneration in Real Life.
  ClinicalTrials.gov Identifier: NCT00549055 - Not yet recruiting
  Neovascular Age-Related Macular Degeneration
  
• Investigation of Macular Pigment Augmentation on Dark Adaptation
  ClinicalTrials.gov Identifier: NCT00478439 - Not yet recruiting
  Aging; Age-Related Macular Degeneration
  
• Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00541333 - Not yet recruiting
  Dry Age Related Macular Degeneration
  
• Phase I Study of Corticosteroid Treatment of Ill-defined Choroidal Neovascularization in Age-related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00001615 - Completed
  Choroidal Neovascularization; Macular Degeneration
  
• A Study of the Safety and Efficacy of an Investigational Drug in Subjects with Subfoveal Choroidal Neovascularization Associated with Age-related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00090532 - Completed
  Age-Related Macular Degeneration
  
• Investigating Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00342251 - Recruiting
  Age-Related Macular Degeneration
  
• Screening for Studies on Retinovascular Diseases
  ClinicalTrials.gov Identifier: NCT00001733 - Recruiting
  Diabetic Retinopathy; Macular Degeneration; Pathologic Neovascularization; Retinal Disease
  
• Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00140803 - Completed
  Age-Related Macular Degeneration
  
• Fluocinolone Implant to Treat Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00008515 - Completed
  Choroidal Neovascularization; Macular Degeneration
  
• Photodynamic and Pharmacologic Treatment of CNV
  ClinicalTrials.gov Identifier: NCT00570193 - Active, not recruiting
  Choroidal Neovascularization; Macular Degeneration
  
• Visudyne® in Occult (VIO)
  ClinicalTrials.gov Identifier: NCT00121407 - Completed
  Macular Degeneration
  
• PDT Vs TTT in Occult CNV in AMD
  ClinicalTrials.gov Identifier: NCT00347906 - Active, not recruiting
  Age-Related Macular Degeneration
  
• Long-Term Efficacy in AMD of Rheopheresis in North America
  ClinicalTrials.gov Identifier: NCT00380172 - Active, not recruiting
  Macular Degeneration
  
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
  ClinicalTrials.gov Identifier: NCT00308477 - Recruiting
  Macular Degeneration; Macular Edema; Branch Retinal Vein Occlusion
  
• The Role of Macular Pigment in Patients With Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00494325 - Recruiting
  Age Related Maculopathy
  
• Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00288561 - Completed
  Age-Related Macular Degeneration (ARMD)
  
• Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)
  ClinicalTrials.gov Identifier: NCT00305630 - Completed
  Choroidal Neovascularization; Age-Related Macular Degeneration